PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model

BMB Rep. 2014 Oct;47(10):569-74. doi: 10.5483/bmbrep.2014.47.10.286.

Abstract

Heme oxygenase-1 (HO-1) degrades heme to carbon dioxide, biliverdin, and Fe2+, which play important roles in various biochemical processes. In this study, we examined the protective function of HO-1 against oxidative stress in SH-SY5Y cells and in a Parkinson's disease mouse model. Western blot and fluorescence microscopy analysis demonstrated that PEP-1-HO-1, fused with a PEP-1 peptide can cross the cellular membranes of human neuroblastoma SH-SY5Y cells. In addition, the transduced PEP-1-HO-1 inhibited generation of reactive oxygen species (ROS) and cell death caused by 1-methyl-4-phenylpyridinium ion (MPP+). In contrast, HO-1, which has no ability to transduce into SH-SY5Y cells, failed to reduce MPP+-induced cellular toxicity and ROS production. Furthermore, intraperitoneal injected PEP-1-HO-1 crossed the blood-brain barrier in mouse brains. In a PD mouse model, PEP-1-HO-1 significantly protected against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity and dopaminergic neuronal death. Therefore, PEP-1-HO-1 could be a useful agent in treating oxidative stress induced ailments including PD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Animals
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Disease Models, Animal*
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / pathology*
  • Heme Oxygenase-1 / pharmacology
  • Heme Oxygenase-1 / therapeutic use*
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Nerve Degeneration / complications
  • Nerve Degeneration / pathology
  • Nerve Degeneration / prevention & control*
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / pathology
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / therapeutic use*
  • Substantia Nigra / drug effects
  • Substantia Nigra / pathology
  • Time Factors
  • Transduction, Genetic

Substances

  • Recombinant Fusion Proteins
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Heme Oxygenase-1
  • PEP-1-heme oxygenase-1 fusion protein